ARTICLE | Company News
Celera, Syrrx proteomics deal
December 12, 2001 8:00 AM UTC
Structural proteomics play Syrrx (San Diego, Calif.) will determine the 3-dimensional structure of potential protein drug targets supplied by CRA, for use in small molecule development. Separately, CR...